Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice
Authors
Keywords
-
Journal
Immunotherapy
Volume 3, Issue 6, Pages 735-746
Publisher
Future Medicine Ltd
Online
2011-06-13
DOI
10.2217/imt.11.59
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeted therapeutic approaches for hormone-refractory prostate cancer
- (2010) Flora Stavridi et al. CANCER TREATMENT REVIEWS
- Presentation of tumour antigens by dendritic cells and challenges faced
- (2010) Neil C Robson et al. CURRENT OPINION IN IMMUNOLOGY
- Current status of immunological therapies for prostate cancer
- (2010) Emmanuel S Antonarakis et al. CURRENT OPINION IN UROLOGY
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy for Prostate Cancer: An Emerging Treatment Modality
- (2010) Charles G. Drake UROLOGIC CLINICS OF NORTH AMERICA
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
- (2009) D. M. Lubaroff et al. CLINICAL CANCER RESEARCH
- Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers
- (2009) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapeutics in Development for Prostate Cancer
- (2009) A. L. Harzstark et al. ONCOLOGIST
- Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer
- (2009) Sol Kim et al. PROSTATE
- Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
- (2008) Lotte Engell-Noerregaard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prostate stem cell antigen: A prospective therapeutic and diagnostic target
- (2008) Adam B. Raff et al. CANCER LETTERS
- Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
- (2008) M. de la Luz Garcia-Hernandez et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now